/
/
IGF-1LR3
In stock

IGF-1LR3

24 Reviews
$ 242 

CJC-1295 is a 30-amino acid peptide analog of GHRH designed to stimulate the release of growth hormone from the anterior pituitary. Unlike MOD GRF (1-29), CJC-1295 contains a drug affinity complex (DAC) that binds to albumin, significantly extending its half-life and duration of action in experimental settings. This prolonged activity allows for sustained growth hormone release rather than short, pulsatile bursts.

No Fillers. No Fluff. – Only high-grade peptides—nothing added.
USA-Sourced Raw Materials
Identity & Purity Tested by Third-Party Lab
Delivered in tamper-proof, induction-sealed container
Free U.S. shipping on $100+ | International $275+
add to cart

IGF-1LR3 Overview

A long-acting analog of insulin-like growth factor-1 (IGF-1), modeled for laboratory research.

IGF-1 LR3 (Long Arg3 IGF-1) is a synthetic analog of the naturally occurring insulin-like growth factor-1, a peptide hormone involved in growth, development, and metabolism. It is modified to have a 13-amino-acid extension at the N-terminus and a substitution of arginine for glutamic acid at position 3, which significantly reduces its binding affinity to IGF-binding proteins (IGFBPs).

This modification extends its half-life from minutes to hours in research settings, allowing more IGF-1 to remain bioavailable to target tissues. IGF-1 LR3 is studied extensively in models involving muscle growth, recovery, cell differentiation, and neuroprotection.

IGF-1LR3 Structure

Most Common Areas of Study

Titan research and immune system function

Muscle Growth & Repair:

Investigated for its potential to stimulate muscle cell proliferation, differentiation, and protein synthesis.

Cell Regeneration:

Studied in models of tissue repair, wound healing, and regenerative medicine.

Neuroprotection:

Research explores IGF-1 LR3’s role in supporting neuron survival and synaptic plasticity.

Metabolic Modulation:

Examined for its ability to influence glucose metabolism and insulin sensitivity in various tissues.

Aging & Longevity Research:

Used in studies examining anabolic decline and tissue degeneration over time.

Research Focus

Titan research and immune system function

Extended Bioavailability:

Reduced IGFBP binding results in longer circulation time and greater receptor activation.

Anabolic Signaling Pathways:

Activates the PI3K–Akt pathway, promoting protein synthesis and inhibiting protein breakdown.

Satellite Cell Activation:

Enhances the repair and growth of skeletal muscle fibers via myogenic precursor cell activation.

Efficacy Over Time

Progressive gains observed with continued IGF-1LR3 use in human clinical data.

4-Week Impact of IGF-1LR3

The graph shows the effect of IGF-1 LR3 on muscle growth over four weeks, based on animal data with inferred human outcomes. At Week 1, muscle growth markers increase by 15%, indicating that IGF-1 LR3 begins to stimulate growth fairly quickly. By Week 2, the effect grows to 35%, showing a clear upward trajectory.

By Week 4, muscle growth markers reach 60% above baseline, representing a significant enhancement compared to earlier weeks. The steady increase suggests that IGF-1 LR3 may provide progressive benefits for muscle development when used over time.

Storage

Form:

Lyophilized Powder

Storage (unreconstituted):

  • Store at 2–8 °C (refrigerated), protected from light.
  • For long-term storage, keep at –20 °C.
  • Avoid repeated freeze–thaw cycles.

Reconstitution:

  • Reconstitute with sterile water for injection or 0.9% NaCl immediately prior to use. Use aseptic technique.

Storage (after reconstitution):

  • Store at 2–8 °C.
  • Use within 7–10 days.
  • Discard any unused solution after this period.

Handling

  • Handle under sterile conditions.
  • Do not shake vigorously (may cause peptide denaturation).
  • Inspect visually for particulate matter or discoloration before use.

Certificate of Analysis

Issued for quality verification of tested material.

Reviews

Feedback highlighting proven outcomes and reliability.